Results 151 to 160 of about 41,581 (185)
Jiangzhi ruanmai recipe alleviates atherosclerosis in ApoE<sup>-/-</sup> mice by regulating cholesterol metabolism involved in gut microbiota remodeling. [PDF]
Front Cardiovasc MedXie G +7 more
europepmc +1 more source
The lipid lowering efficacy of PCSK9 inhibitors alone vs. statins alone: a meta-analysis. [PDF]
Front Cardiovasc MedKyan K, Gornbein J, Saver J.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Expert Opinion on Pharmacotherapy, 2005
The introduction of statins has drastically changed the treatment and prevention of atherosclerotic vascular disease. By lowering lipid levels and reducing the risk of coronary heart disease, these drugs are among the most effective at reducing morbidity and mortality available to clinical practice.
Sander I, van Leuven +1 more
openaire +2 more sources
The introduction of statins has drastically changed the treatment and prevention of atherosclerotic vascular disease. By lowering lipid levels and reducing the risk of coronary heart disease, these drugs are among the most effective at reducing morbidity and mortality available to clinical practice.
Sander I, van Leuven +1 more
openaire +2 more sources
Drugs, 2007
Extensive data are available on the safety of atorvastatin from randomised clinical trials, postmarketing analyses and reports to regulatory agencies. Atorvastatin is generally well tolerated across the range of therapeutic dosages, with the exception of a slightly higher rate of liver enzyme elevations with atorvastatin 80 mg/day which does not appear
openaire +3 more sources
Extensive data are available on the safety of atorvastatin from randomised clinical trials, postmarketing analyses and reports to regulatory agencies. Atorvastatin is generally well tolerated across the range of therapeutic dosages, with the exception of a slightly higher rate of liver enzyme elevations with atorvastatin 80 mg/day which does not appear
openaire +3 more sources